Status:
COMPLETED
Addition of Pyridostigmine to Conventional Management of Postdural Puncture Headache
Lead Sponsor:
Ain Shams University
Conditions:
Postdural Puncture Headache
Eligibility:
All Genders
20-40 years
Phase:
PHASE4
Brief Summary
Postdural puncture headache (PDPH) is a major complication of neuraxial anesthesia that can occur following spinal anesthesia and with inadvertent Dural puncture during epidural anesthesia. The presen...
Eligibility Criteria
Inclusion
- Patients American Society of anesthesiologists' physical status (ASA) II because of pregnancy.
- Patients diagnosed with Postdural puncture headache following intrathecal spinal anesthesia for elective caesarean delivery.
Exclusion
- Patients with PDPH and a visual analog scale (VAS) score \<5.
- Patients with history of chronic headache, cluster headache, migraine, convulsions.
- Patients with history of cerebrovascular accident, previous neurological diseases.
- Patients with preeclampsia, eclampsia, coagulopathy.
- Patients with severe bleeding (\>20% of blood volume).
- Patients undergoing treatment with vasopressors.
- Patients with bronchial asthma.
- Patients with arrhythmia, and any type of heart block.
Key Trial Info
Start Date :
July 25 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 3 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05969119
Start Date
July 25 2023
End Date
January 3 2024
Last Update
September 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Suez General Hospital
Suez, Egypt